ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0IMT Photocure Asa

29.95
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Photocure Asa LSE:0IMT London Ordinary Share NO0010000045 PHOTOCURE ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 29.95 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 374.47M -71.86M -2.6495 -11.30 812.27M

Photocure ASA: Invitation to presentation of first quarter 2023 financial results

03/05/2023 10:52am

PR Newswire (US)


Photocure Asa (LSE:0IMT)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Photocure Asa Charts.

OSLO, Norway, May 3, 2023 /PRNewswire/ -- Photocure ASA (Photocure) (PHO: OSE) will announce the first quarter 2023 financial results on Wednesday 10 May 2023 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.

The quarterly report and presentation will be published at 08:00 CEST and will be publicly available at www.photocure.com.

The investor presentation will be streamed live and be hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45 CEST.

The streaming event is available through https://channel.royalcast.com/landingpage/hegnarmedia/20230510_9/.

For further information, please contact:

Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com

Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

The following files are available for download:

https://mb.cision.com/Main/17498/3762741/2029596.pdf

Release

 

Cision View original content:https://www.prnewswire.com/news-releases/photocure-asa-invitation-to-presentation-of-first-quarter-2023-financial-results-301814449.html

SOURCE Photocure

Copyright 2023 PR Newswire

1 Year Photocure Asa Chart

1 Year Photocure Asa Chart

1 Month Photocure Asa Chart

1 Month Photocure Asa Chart

Your Recent History

Delayed Upgrade Clock